Heng Cao

569 total citations
37 papers, 358 citations indexed

About

Heng Cao is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Rheumatology. According to data from OpenAlex, Heng Cao has authored 37 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 12 papers in Epidemiology and 11 papers in Rheumatology. Recurrent topics in Heng Cao's work include Inflammatory Myopathies and Dermatomyositis (9 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers) and Eosinophilic Disorders and Syndromes (4 papers). Heng Cao is often cited by papers focused on Inflammatory Myopathies and Dermatomyositis (9 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers) and Eosinophilic Disorders and Syndromes (4 papers). Heng Cao collaborates with scholars based in China, Australia and United Kingdom. Heng Cao's co-authors include Jin Lin, Junyu Liang, Yini Ke, Yiduo Sun, Chuanyin Sun, Guanhua Xu, David W. Hedley, Ye He, Fred Kirsten and Alan B. P. Ng and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Frontiers in Immunology.

In The Last Decade

Heng Cao

34 papers receiving 351 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heng Cao China 11 103 94 77 69 65 37 358
Hirotsugu Hashimoto Japan 11 162 1.6× 61 0.6× 55 0.7× 45 0.7× 39 0.6× 65 360
Silvia Münster Germany 7 75 0.7× 66 0.7× 40 0.5× 103 1.5× 39 0.6× 7 369
Çiğdem Vural Türkiye 13 85 0.8× 45 0.5× 63 0.8× 86 1.2× 51 0.8× 57 401
Jie Lin China 14 170 1.7× 49 0.5× 48 0.6× 38 0.6× 48 0.7× 48 512
Matteo Longhi Italy 12 124 1.2× 48 0.5× 54 0.7× 56 0.8× 59 0.9× 21 343
Yukari Ichikawa Japan 12 279 2.7× 174 1.9× 62 0.8× 48 0.7× 118 1.8× 32 492
Taeuk Kang South Korea 13 73 0.7× 50 0.5× 32 0.4× 36 0.5× 39 0.6× 33 341
In Ho Choi South Korea 13 144 1.4× 66 0.7× 90 1.2× 73 1.1× 65 1.0× 53 465
Heng Wang China 11 60 0.6× 31 0.3× 63 0.8× 106 1.5× 110 1.7× 76 462
Yuri Masui Japan 14 71 0.7× 102 1.1× 71 0.9× 110 1.6× 55 0.8× 30 452

Countries citing papers authored by Heng Cao

Since Specialization
Citations

This map shows the geographic impact of Heng Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heng Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heng Cao more than expected).

Fields of papers citing papers by Heng Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heng Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heng Cao. The network helps show where Heng Cao may publish in the future.

Co-authorship network of co-authors of Heng Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Heng Cao. A scholar is included among the top collaborators of Heng Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heng Cao. Heng Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ji, Lei, Zhuoran Li, Heng Cao, et al.. (2025). Association of quality of life in older patients with breast cancer: a cross-sectional study from China. BMJ Open. 15(1). e085842–e085842. 1 indexed citations
2.
Cao, Heng, et al.. (2025). Hypoxia-activated oxidative stress mediates SHP2/PI3K signaling pathway to promote hepatocellular carcinoma growth and metastasis. Scientific Reports. 15(1). 4847–4847. 4 indexed citations
3.
4.
Liang, Junyu, Liyan Wan, Yake Yao, et al.. (2024). An externally validated clinical-laboratory nomogram for myocardial involvement in adult idiopathic-inflammatory-myopathy patients. Clinical Rheumatology. 43(6). 1959–1969. 2 indexed citations
5.
Yang, Hua, Ruhui Ma, Tao Song, et al.. (2022). Perceptual Data Augmentation for Biomedical Coronary Vessel Segmentation. IEEE/ACM Transactions on Computational Biology and Bioinformatics. 20(4). 2494–2505. 7 indexed citations
6.
Cao, Heng, Jiao Huang, Jie Chang, et al.. (2022). Predictors of progression in idiopathic inflammatory myopathies with interstitial lung disease. Journal of Translational Internal Medicine. 11(1). 46–56. 8 indexed citations
7.
Li, Shuangshuang, Guanhua Xu, Junyu Liang, et al.. (2022). The Role of Advanced Imaging in Gout Management. Frontiers in Immunology. 12. 811323–811323. 14 indexed citations
8.
Xu, Guanhua, Jin Lin, Junyu Liang, et al.. (2021). Entheseal involvement of the lower extremities in gout: an ultrasonographic descriptive observational study. Clinical Rheumatology. 40(11). 4649–4657. 6 indexed citations
9.
Liang, Junyu, Heng Cao, Bowen Wu, et al.. (2021). Clinical Value of 18F-FDG PET/CT Scan and Cytokine Profiles in Secondary Hemophagocytic Lymphohistiocytosis in Idiopathic Inflammatory Myopathy Patients: A Pilot Study. Frontiers in Immunology. 12. 745211–745211. 6 indexed citations
10.
Cao, Heng, Junyu Liang, Jing Liu, et al.. (2021). Novel Effects of Combination Therapy Through Inhibition of Caspase-1/Gasdermin D Induced-Pyroptosis in Lupus Nephritis. Frontiers in Immunology. 12. 720877–720877. 46 indexed citations
11.
Liang, Junyu, Heng Cao, Yang Yang, et al.. (2021). Efficacy and Tolerability of Nintedanib in Idiopathic-Inflammatory-Myopathy-Related Interstitial Lung Disease: A Pilot Study. Frontiers in Medicine. 8. 626953–626953. 22 indexed citations
12.
Liang, Junyu, Heng Cao, Yini Ke, et al.. (2020). Acute Exacerbation of Interstitial Lung Disease in Adult Patients With Idiopathic Inflammatory Myopathies: A Retrospective Case-Control Study. Frontiers in Medicine. 7. 12–12. 14 indexed citations
13.
Cao, Heng, Caijuan Huan, Qin Wang, et al.. (2020). Predicting Survival Across Acute Exacerbation of Interstitial Lung Disease in Patients with Idiopathic Inflammatory Myositis: The GAP-ILD Model. Rheumatology and Therapy. 7(4). 967–978. 10 indexed citations
14.
Liang, Junyu, Danyi Xu, Chuanyin Sun, et al.. (2019). Hemophagocytic Lymphohistiocytosis: Prevalence, Risk Factors, Outcome, and Outcome-related Factors in Adult Idiopathic Inflammatory Myopathies. The Journal of Rheumatology. 47(10). 1532–1540. 10 indexed citations
15.
Jiang, Wen, Ke Liu, Qing Guo, et al.. (2017). Tumor-infiltrating immune cells and prognosis in gastric cancer: a systematic review and meta-analysis. Oncotarget. 8(37). 62312–62329. 46 indexed citations
16.
Ling, Tianlong, et al.. (2015). Turning left or right? A comparative analysis in adenocarcinomas of the esophagogastric junction according to the seventh AJCC TNM classification for cancers of the esophagus and stomach: experience in a Chinese single institution.. PubMed. 8(7). 10668–77. 6 indexed citations
17.
Cao, Heng, Wen Gao, & Hongli Li. (2014). Role of peroxisome proliferator-activated receptor α in atherosclerosis. Molecular Medicine Reports. 9(5). 1755–1760. 11 indexed citations
18.
Cao, Heng. (2012). Renal Sympathetic Denervation for Treatment of Resistant Hypertension. 1 indexed citations
19.
Cao, Heng. (2003). Effect of zoloft on cerebral apoplexy patients with depressive symptoms. 1 indexed citations
20.
Hou, Lingling, et al.. (2002). [Study of in vitro expansion and differentiation into neuron-like cells of human umbilical cord blood mesenchymal stem cells].. PubMed. 23(8). 415–9. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hirotsugu Hashimoto Breakdown of academic impact, for papers by Silvia Münster Breakdown of academic impact, for papers by Çiğdem Vural Breakdown of academic impact, for papers by Jie Lin Breakdown of academic impact, for papers by Matteo Longhi Breakdown of academic impact, for papers by Yukari Ichikawa Breakdown of academic impact, for papers by Taeuk Kang Breakdown of academic impact, for papers by In Ho Choi Breakdown of academic impact, for papers by Heng Wang Breakdown of academic impact, for papers by Yuri Masui
Rankless by CCL
2026